Cargando…
OR25-05 Clinical Predictors Of Symptomatic Benefit In Men With Low Testosterone During Testosterone Treatment Compared With Placebo: Results Of Individual Patient And Aggregate Data Meta-analyses
Disclosure: J. Hudson: None. M. Cruickshank: None. R. Quinton: Speaker; Self; Bayer Schering Pharma, Besins. L. Aucott: None. F.C. Wu: None. M. Grossmann: None. S. Bhasin: None. P.J. Snyder: None. S. Ellenberg: None. T.G. Travison: None. G.B. Brock: None. E.J. Gianatti: None. Y.T. van der Schouw: No...
Autores principales: | Hudson, Jemma, Cruickshank, Moira, Quinton, Richard, Aucott, Lorna, Wu, Frederick C, Grossmann, Mathis, Bhasin, Shalender, Snyder, Peter J, Ellenberg, Susan, Travison, Thomas G, Brock, Gerald B, Jaye Gianatti, Emily, van der Schouw, Yvonne T, Emmelot-Vonk, Marielle H, Giltay, Erik J, Geoff, Hackett, Ramachandran, Sudarshan, Bernhard Svartberg, Johan, Hildreth, Kerry L, Groti Antonic, Kristina, Tenover, Joyce S, Meng Tan, Hui, Chee Kong, Christopher Ho, Wei Shen, Tan, Marks, Leonard S, Ross, Richard John M, Schwartz, Robert S, Roberts, Stephen, Andersen, Marianne, Magnussen, Line, Aceves-Martins, Magaly, Bhattacharya, Siladitya, Singh Dhillo, Waljit, Brazzelli, Miriam, Nalin Jayasena, Channa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555273/ http://dx.doi.org/10.1210/jendso/bvad114.1704 |
Ejemplares similares
-
OR25-5 Adverse Cardiovascular Events and Cause Mortality in Men During Testosterone Treatment: Individual Patient and Aggregate Data Meta-Analyses
por: Andersen, Marianne, et al.
Publicado: (2022) -
Adverse cardiovascular events and mortality in men during testosterone treatment: an individual patient and aggregate data meta-analysis
por: Hudson, Jemma, et al.
Publicado: (2022) -
PMON258 Patient-Reported Outcomes for men with Hypogonadism and the Impact of Low Testosterone Levels: a review of measures
por: Jayasena, Channa N, et al.
Publicado: (2022) -
PMON260 Cost-Effectiveness of Testosterone Treatment for Men with Hypogonadism
por: Jayasena, Channa, et al.
Publicado: (2022) -
Identifying the outcomes important to men with hypogonadism: A qualitative evidence synthesis
por: Aceves‐Martins, Magaly, et al.
Publicado: (2022)